Cerecin
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Colorado, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
44 Cook St Ste 100-71, Denver, Colorado,...Phone Number
+65 68132999Website
www.cerecin.comRevenue
$5.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Cerecin
Cerecin is a global healthcare company with almost 20 years of innovation and leadership in brain health.At Cerecin we think differently. We develop novel evidence-based solutions that help people; pharmaceuticals, medical foods, diagnostics, medical devices and e-health products. These solutions target conditions ranging from memory impairment to some of the most devastating neurological diseases.Explore more
Cerecin Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cerecin your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Cerecin has new funding data
Check out if Cerecin is spiking on competitors!
Check if Cerecin has recently received funding, and reach out quickly before it becomes old news!
Click to see if Cerecin had a recent Job posting/layoffs
Cerecin, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Cerecin recently announced quarterly report
Product Launch: Get notified when Cerecin launches new products
Congratulate Masked Content for being promoted to Masked Content at Cerecin
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Cerecin
Find 2 more new buyers
Compare Similar Companies to Cerecin
Compare insights from companies similar to Cerecin, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cerecin is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cerecin is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cerecin.
Cerecin financials insights
Gather financial insights about Cerecin, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Series B
$7.5M
2008
Series C
$35M
Private Equity
$26.1M
2009
Series A
$12M
2010
Private Equity
$9.5M
Series D
$11M
2011
Debt
$3.9M
2012
Debt
$4.9M
Private Equity
$84.1M
2021
Other Financing Round
$40M
Cerecin Tech Stack
A closer look at the technologies used by Cerecin
See more technologies
Most Recent Scoops
Left Company
Executive Move
New Hire
Executive Move
Executive Moves
Funding
New Hire
Executive Move
Funding
Cerecin News & Media
Cerecin Announces Publication of Clinical Study Demonstrating Promising Results of CER-0001 (tricaprilin) for Rare Pediatric Epilepsy
Study showed that the investigational ketogenic drug was generally well tolerated and demonstrated seizure reduction in infants with rare drug-resistant epileptic spasms. Phase 1/2a study supports further development as a metabolic therapy for rare developmental and epileptic...Cerecin Joins NIHR HealthTech Research Centre in Brain Health as an Industry Partner
DENVER, Aug. 27, 2025 /PRNewswire/ -- Cerecin, a global biotech company focused on neurometabolism, is proud to announce its partnership with the NIHR HealthTech Research Centre (HRC) in Brain Health, joining a distinguished group of industry leaders including GE Healthcare, Novo Nordisk, Roche Diagnostics, and Camtech Innovations. The HRC, based at King's College London and the South London and Maudsley NHS Foundation Trust, is dedicated to advancing the diagnosis, care, and treatment of dementCerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders.
Cerecin and IMCB signed a Memorandum of Understanding to collaborate in the areas of neurometabolism, neurodegeneration, metabolic regulators, and brain health and function. SINGAPORE and DENVER, Nov. 30, 2023 /PRNewswire/ -- Cerecin Inc., a clinical-stage biotechnology company at the...Cerecin strengthens position in neurometabolism with addition to pipeline
Cerecin completes in-licensing of an investigational radiolabelled tracer 18FBHB, CER-022, for development and use in positron emission tomography (PET) studies of ketone body metabolism Company expands ketogenic platform following pilot data of CER-0001 in migraine and infantile spasms....
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cerecin
Sign Up For FreeTo access detailed company insights
Cerecin is a global healthcare company with almost 20 years of innovation and leadership in brain health.At Cerecin we think differently. We develop novel evidence-based solutions that help people; pharmaceuticals, medical foods, diagnostics, medical devices and e-health products. These solutions target conditions ranging from memory impairment to... Read More
